Search Results
Jun 23, 2026, 08:00 ET Rapalogix Health Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin Health
Health raises $20M Series A to advance longevity-based skin health and expand Re-Q nationally.Founded by skin longevity scientist Rahul Mehta, PhD, renowned dermatologist Doris Day, MD, and leading healthcare executive Brent Saunders, Rapalogix was created with a simple but ambitious vision: to
More news about: Rapalogix Health, Inc.
Jun 23, 2026, 07:00 ET Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board
include:Joseph Bonventre, MD, PhD, Harvard Medical SchoolMatthias Kretzler, MD, PhD, University of MichiganDavid Cherney, MD, PhD, FRCP University of TorontoJonathan Barratt, MD, PhD, FRCP University of Leicester"Fibrosis
More news about: Mediar Therapeutics
Jun 22, 2026, 17:30 ET World Allergy Week 2026 Calls for Improved Access to Allergy Care Worldwide
confusion."Some of the barriers to accessing appropriate care include misdiagnosis, under-treatment, and health inequities, according to Elham Hossny, MD, PhD, of Ain Shams University Children's Hospital in Cairo, and Chair of World Allergy Week 2026. "In most countries, allergy specialists are under-recognized
More news about: World Allergy Organization
Jun 22, 2026, 15:00 ET OMNICOM MEDIA BECOMES NETFLIX'S FIRST DATA COLLABORATION PARTNER FOR AI-POWERED AD CREATIVES
enable the world's most ambitious businesses to grow faster and smarter. The Omnicom Media portfolio includes global media agency brands OMD, Initiative, PHD, UM, Hearts & Science, and Mediahub; core Omnicom Integrated Media offerings Acxiom, the world's premier identity solution, and the Flywheel digital
More news about: Omnicom Media
Jun 22, 2026, 14:14 ET Phanes Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of Spevatamig in Combination with Chemotherapy for the Frontline Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
important milestone in our mission to advance innovative therapies that help improve outcomes for patients with hard-to-treat cancers," said Ming Wang, PhD, MBA, CEO of Phanes. "PDAC is the first cancer type we are targeting with spevatamig; there is more to come."Spevatamig is a bispecific antibody
More news about: Phanes Therapeutics, Inc.
Jun 22, 2026, 13:18 ET Texas A&M Study Highlights Pictor PictVet® as a Promising New Tool for Non-Invasive Beef Cattle Health Monitoring
and adds to the growing body of research evaluating targeted proteomic approaches across animal health applications."— Jamie Platt, PhD, CEO and Co-founder, Pictor Holdings Inc.This publication represents the fourth independent peer-reviewed publication on the applications
More news about: Pictor Holdings Inc.
Jun 22, 2026, 13:08 ET Texas A&M Study Highlights Pictor PictVet® as a Promising New Tool for Non-Invasive Beef Cattle Health Monitoring
and adds to the growing body of research evaluating targeted proteomic approaches across animal health applications."— Jamie Platt, PhD, CEO and Co-founder, Pictor Holdings Inc.This publication represents the fourth independent peer-reviewed publication on the applications
More news about: Pictor Holdings Inc.
Jun 22, 2026, 12:00 ET New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents
Dr. Morgan Cutlip, PhD in psychology and mental load expert. "While online communities can reduce isolation and offer reassurance, the highly curated nature of parenting content
More news about: Abbott
Jun 22, 2026, 11:07 ET Digital Health Tools Are Reshaping Healthcare in the United States
routine part of everyday patient care across America, not simply side channels used occasionally," said study senior investigator Michal A. Mankowski, PhD.Dr. Mankowski, an assistant professor in the Department of Surgery at NYU Grossman School of Medicine, said the study demonstrates that patients
More news about: NYU Langone Health System
Jun 22, 2026, 11:00 ET The American Board of Medical Specialties Announces 2026 Service Award Recipients
programming that directly addresses the needs of children throughout the country.ABMS Distinguished Scholar Award: Daniel J. Schumacher, MD, PhD, MEdNewly established, the ABMS Distinguished Scholar Award recognizes past
More news about: American Board of Medical Specialties
Jun 22, 2026, 10:16 ET New Alzheimer's & Dementia Paper Highlights SpeechDx's Role in Advancing AI-Driven Tools for Earlier Alzheimer's Detection and Risk Assessment
diagnosis, but truly getting ahead of this disease will require digital and AI tools that can predict cognitive decline before it starts," said Melissa Lee, PhD, Director of the Diagnostics Accelerator (DxA) at the Alzheimer's Drug Discovery Foundation (ADDF) and lead author of the paper. "Speech is one of the
More news about: Alzheimer's Drug Discovery Foundation
Jun 22, 2026, 10:06 ET Integral Molecular Earns Back-to-Back Top Workplace Honors from The Philadelphia Inquirer
Workplaces named by the Philadelphia Inquirer"We are incredibly proud to be recognized once again as a Top Workplace," said Sharon Willis, PhD, Co-founder of Integral Molecular. "This award reflects our commitment to scientific excellence, collaboration, and innovation, as well as the strong
More news about: Integral Molecular
Jun 22, 2026, 09:11 ET Betrayal Is a Public Health and Workplace Crisis. New Research of 73,500 People Finally Proves It -- and Provides the Path Through.
required • Full Report: free with email • Corporate Tier: organizational brief + direct debrief with Dr. SilberDr. Debi Silber, PhD is the world's leading expert in betrayal recovery and the founder and CEO of The PBT® Institute — the world's leading organization devoted to betrayal
More news about: The PBT Institute
Jun 22, 2026, 09:00 ET U.S. Biomedical Innovation Leadership at Risk: New Data Show China Rapidly Closing Gap as Clinical Trials and Manufacturing Migrate Abroad
CurePanelists:Vanessa Almendro Navarro, PhD, Chief Commercial Officer, City of HopeYan Ling, PhD, Executive Director, Head of Research Innovation China, Takeda PharmaceuticalsJue Wang, PhD, Vice President and Global Head of Business Development, Insilico MedicineAbout
More news about: Cure.
Jun 22, 2026, 09:00 ET EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots
Click HereThe session will be presented by Prof. Jeffrey Rosenfeld, MD, PhD, FAAN, Professor of Neurology and Director of the Neuromuscular ALS/MND Program at Loma Linda University School of Medicine. With more than 30 years
More news about: NeuroSense
Jun 22, 2026, 08:30 ET How to Prepare for a Successful Drug Marketing Application Submission, Upcoming Webinar Hosted by Xtalks
Premier Research, Cathy Gatza, PhD, Vice President, Regulatory Strategy; and Elizabeth Narciso, Vice President, Regulatory Operations, for the live webinar on Tuesday, July 14, 2026, at
More news about: Xtalks
Jun 22, 2026, 08:13 ET First Patient in the World Treated With Gene Therapy for Cockayne Syndrome
Miguel Sena-Esteves, PhD, associate professor of neurology and genetic & cellular medicine at UMass Chan Medical School and director of the Translational Institute for
More news about: Riaan Research Initiative
Jun 22, 2026, 08:00 ET Brenig Therapeutics to Present AI-Enabled Design of a Brain-Penetrant NLRP3 Inhibitor at Keystone Symposia Neuroinflammation in Health and Disease
biotechnology company developing differentiated therapies for neurodegenerative and neuroinflammatory diseases, today announced that Alexei Pushechnikov, PhD, will present new data on the company's brain-penetrant NLRP3 inhibitor program at the upcoming Keystone Symposia meeting, Neuroinflammation in
More news about: Brenig Therapeutics Inc
Jun 22, 2026, 08:00 ET World's Largest Perinatal Mental Health Conference Kicks Off This Week in Los Angeles; Community to Share Developments, Build Awareness, Shatter Stigma Around Postpartum Depression and More
one another, share innovative practices, and strengthen the systems of care that support families during pregnancy and postpartum," said Wendy Davis, PhD, PMH-C, President and CEO of Postpartum Support International. "As awareness of maternal mental health continues to grow, so does our collective responsibility
More news about: Postpartum Support International
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
dermatitis and inflammatory bowel disease. Seed financed by Sofinnova Partners, Bionyra was co-founded by Sofinnova Partners and Frédéric Marrache, MD, PhD, MBA, a former Sanofi R&D executive with deep immunology expertise. The company is committed to overcoming the limitations of existing therapies
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 Million
dermatitis and inflammatory bowel disease. Seed financed by Sofinnova Partners, Bionyra was co-founded by Sofinnova Partners and Frédéric Marrache, MD, PhD, MBA, a former Sanofi R&D executive with deep immunology expertise. The company is committed to overcoming the limitations of existing therapies
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical gibt Lizenzvereinbarung mit Bionyra Pharma über zwei monoklonale und bispezifische Antikörper der nächsten Generation zur Behandlung immunvermittelter Entzündungskrankheiten im Wert von bis zu 985 Millionen US-Dollar bekannt
liegt. Bionyra, dessen Startkapital von Sofinnova Partners bereitgestellt wurde, wurde gemeinsam von Sofinnova Partners und Dr. med. Frédéric Marrache, PhD, MBA, einer ehemaligen Führungskraft im Bereich Forschung und Entwicklung bei Sanofi mit fundierten Fachkenntnissen in der Immunologie, gegründet. Das
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 08:00 ET TrueLab Biopharmaceutical anuncia un acuerdo de licencia con Bionyra Pharma
enfermedad inflamatoria intestinal. Financiada inicialmente por Sofinnova Partners, Bionyra fue cofundada por Sofinnova Partners y Frédéric Marrache, MD, PhD, MBA, exejecutivo de I+D de Sanofi con amplia experiencia en inmunología. La compañía se compromete a superar las limitaciones de las terapias existentes
More news about: TrueLab Biopharmaceutical Co., Ltd.
Jun 22, 2026, 07:00 ET Consello Expands UK Geopolitical Advisory with New Hire Wolfango Piccoli
Eurozone crisis and advising financial institutions, corporations, and public sector clients on political and economic risk across the region. He has a PhD in International Politics from the University of Wales, Aberystwyth, and a Master of Arts in International Relations from Bilkent University.Consello's
More news about: Consello
Jun 22, 2026, 07:00 ET Consello Expands UK Geopolitical Advisory with New Hire Wolfango Piccoli
Eurozone crisis and advising financial institutions, corporations, and public sector clients on political and economic risk across the region. He has a PhD in International Politics from the University of Wales, Aberystwyth, and a Master of Arts in International Relations from Bilkent University.Consello's
More news about: Consello